Serveur d'exploration SRAS - Exploration (Accueil)

Index « AbsEn.i » - entrée « proteins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
proteinchip < proteins < proteinuria  Facettes :

List of bibliographic references indexed by proteins

Number of relevant bibliographic references: 891.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000030 (2020) Yeyan He [République populaire de Chine] ; Chanying Zheng [République populaire de Chine][Replication and transmission mechanisms of highly pathogenic human coronaviruses].
000070 (2020) Sergio Rosales-Mendoza [Mexique] ; Ver Nica A. Márquez-Escobar [Mexique] ; Omar González-Ortega [Mexique] ; Ricardo Nieto-G Mez [Mexique] ; Jaime I. Arévalo-Villalobos [Mexique]What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?
000147 (2020) Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada]The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
000185 (2020) Rameez Jabeer Khan [Inde] ; Rajat Kumar Jha [Inde] ; Gizachew Muluneh Amera [Inde] ; Monika Jain [Inde] ; Ekampreet Singh [Inde] ; Amita Pathak [Inde] ; Rashmi Prabha Singh [Inde] ; Jayaraman Muthukumaran [Inde] ; Amit Kumar Singh [Inde]Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase.
000196 (2020) Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis]Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
000201 (2020) Swatantra Kumar [Inde] ; Vimal K. Maurya [Inde] ; Anil K. Prasad [Inde] ; Madan L B. Bhatt [Inde] ; Shailendra K. Saxena [Inde]Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).
000202 (2020) Mushtaq Hussain [Pakistan] ; Nusrat Jabeen [Pakistan] ; Fozia Raza [Pakistan] ; Sanya Shabbir [Pakistan] ; Ayesha A. Baig [Pakistan] ; Anusha Amanullah [Pakistan] ; Basma Aziz [Pakistan]Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.
000207 (2020) Suhas Srinivasan [États-Unis] ; Hongzhu Cui [États-Unis] ; Ziyang Gao [États-Unis] ; Ming Liu [États-Unis] ; Senbao Lu [États-Unis] ; Winnie Mkandawire [États-Unis] ; Oleksandr Narykov [États-Unis] ; Mo Sun [États-Unis] ; Dmitry Korkin [États-Unis]Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.
000223 (2020) Furong Qi [République populaire de Chine] ; Shen Qian [République populaire de Chine] ; Shuye Zhang [République populaire de Chine] ; Zheng Zhang [République populaire de Chine]Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
000230 (2020) Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker [États-Unis] ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie]Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids
000245 (2020) Anu Haveri [Finlande] ; Teemu Smura [Finlande] ; Suvi Kuivanen [Finlande] ; Pamela Österlund [Finlande] ; Jussi Hepojoki [Suisse] ; Niina Ikonen [Finlande] ; Marjaana Pitk Paasi [Finlande] ; Soile Blomqvist [Finlande] ; Esa Rönkkö [Finlande] ; Anu Kantele [Finlande] ; Tomas Strandin [Finlande] ; Hannimari Kallio-Kokko [Finlande] ; Laura Mannonen [Finlande] ; Maija Lappalainen [Finlande] ; Markku Broas [Finlande] ; Miao Jiang [Finlande] ; Lotta Siira [Finlande] ; Mika Salminen [Finlande] ; Taneli Puumalainen [Finlande] ; Jussi Sane [Finlande] ; Merit Melin [Finlande] ; Olli Vapalahti [Finlande] ; Carita Savolainen-Kopra [Finlande]Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020.
000282 (2020) Markus Hoffmann [Allemagne] ; Hannah Kleine-Weber [Allemagne] ; Simon Schroeder [Allemagne] ; Nadine Krüger [Allemagne] ; Tanja Herrler [Allemagne] ; Sandra Erichsen [Autriche] ; Tobias S. Schiergens [Allemagne] ; Georg Herrler [Allemagne] ; Nai-Huei Wu [Allemagne] ; Andreas Nitsche [Allemagne] ; Marcel A. Müller [Russie] ; Christian Drosten [Allemagne] ; Stefan Pöhlmann [Allemagne]SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
000290 (2020) Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela]Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis
000296 (2020) Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie]Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity
000314 (2020) Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Emma Woolner [Canada] ; Jason K. Perry [États-Unis] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Gotte [Canada]Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
000317 (2020) Ashleigh Shannon [France] ; Nhung Thi Tuyet Le [France] ; Barbara Selisko [France] ; Cecilia Eydoux [France] ; Karine Alvarez [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] ; Olve Peersen [États-Unis, France] ; Francois Ferron [France] ; Bruno Canard [France]Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
000376 (2020) Syed Faraz Ahmed ; Ahmed A. Quadeer ; Matthew R. Mckay [République populaire de Chine]Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
000426 (2020) James Lyons-WeilerPathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity
000441 (2020) Henry Ji [États-Unis] ; Ying Yan [États-Unis] ; Beibei Ding [États-Unis] ; Wenzhong Guo [États-Unis] ; Mark Brunswick [États-Unis] ; Andreas Niethammer [États-Unis] ; Williams Soohoo [États-Unis] ; Robin Smith [États-Unis] ; Alexis Nahama [États-Unis] ; Yanliang Zhang [États-Unis]Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus.
000457 (2020) Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis]Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
000465 (2020) A. A. DawoodMutated COVID-19 may foretell a great risk for mankind in the future

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "proteins" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    proteins
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021